Premium
Time to Expand the Mitra‐Clip Indications
Author(s) -
Marmagkiolis Konstantinos,
Cilingiroglu Mehmet
Publication year - 2015
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.26225
Subject(s) - medicine , mitraclip , selection (genetic algorithm) , patient safety , vascular access , major bleeding , surgery , medical emergency , intensive care medicine , cardiology , mitral regurgitation , health care , myocardial infarction , artificial intelligence , economics , economic growth , hemodialysis , computer science
Key points MitraClip implantation yields low in‐patient MACCE even in higher‐risk patients. Bleeding and vascular complications remain the most important procedural related complications. Development of smaller caliber devices, investigation of alternative access techniques to improve safety and better patient selection are needed to optimize the outcomes of this procedure.